Assessing Brain Capillaries in Coronavirus Disease 2019 | Infectious Diseases | JAMA Neurology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Helms  J, Kremer  S, Merdji  H,  et al.  Neurologic features in severe SARS-CoV-2 infection.   N Engl J Med. 2020;382(23):2268-2270. doi:10.1056/NEJMc2008597Google ScholarCrossref
Couzin-Frankel  J. From ‘brain fog’ to heart damage, COVID-19’s lingering problems alarm scientists. Science. Published July 31, 2020. Accessed January 28, 2021. doi:10.1126/science.abe1147
Mukerji  SS, Solomon  IH.  What can we learn from brain autopsies in COVID-19?   Neurosci Lett. 2021;742:135528. doi:10.1016/j.neulet.2020.135528PubMedGoogle Scholar
Jensen  MP, Le Quesne  J, Officer-Jones  L,  et al.  Neuropathological findings in two patients with fatal COVID-19.   Neuropathol Appl Neurobiol. Published online September 8, 2020. doi:10.1111/nan.12662PubMedGoogle Scholar
Duarte-Neto  AN, Monteiro  RAA, da Silva  LFF,  et al.  Pulmonary and systemic involvement in COVID-19 patients assessed with ultrasound-guided minimally invasive autopsy.   Histopathology. 2020;77(2):186-197. doi:10.1111/his.14160PubMedGoogle ScholarCrossref
Rapkiewicz  AV, Mai  X, Carsons  SE,  et al.  Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series.   EClinicalMedicine. 2020;24:100434. doi:10.1016/j.eclinm.2020.100434PubMedGoogle Scholar
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    Views 37,575
    Citations 0
    Research Letter
    February 12, 2021

    Assessing Brain Capillaries in Coronavirus Disease 2019

    Author Affiliations
    • 1Department of Pathology, Johns Hopkins University, Baltimore, Maryland
    • 2Department of Otolaryngology, Johns Hopkins University, Baltimore, Maryland
    • 3Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts
    JAMA Neurol. Published online February 12, 2021. doi:10.1001/jamaneurol.2021.0225

    Evidence suggests brain involvement in coronavirus disease 2019 (COVID-19). Manifestations in acutely ill individuals often include confusion and alteration of consciousness. After this phase, many patients experience continued neurologic symptoms such as dysexecutive syndrome1 or “brain fog.”2 However, in autopsies from patients with COVID-19 who had neurologic abnormalities (reviewed in the study by Mukerji and Solomon3), investigations have largely not identified the chronic inflammation or marked neural changes typically associated with viral infection, and viral genetic material has been minimal or absent. It has been difficult to reconcile the experience of patients and clinicians that COVID-19 is altering cognition with tissue studies that show no evidence of encephalitis involving higher brain centers. We hypothesized that histopathology might provide insight. We report here a finding that may contribute in some cases, identified by analysis of brain tissue from patients who died of COVID-19.